SQSTM1 and Behcet disease: Since we used immunohistochemistry for the specific detection of the lesions our findings may be less biased than the studies from 19353 and 19556 because of superior methodology for the detection of the BD-lesions, which is now available with highly specific immunohistochemical markers such as anti-p62/SQSTM1 and anti-APP antibodies.